Theorem Clinical Research

Global News

Johnson & Johnson to acquire Alios BioPharma

Wednesday, October 1, 2014 01:04 PM

Johnson & Johnson has announced a definitive agreement to acquire Alios BioPharma, a San Francisco-based, privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.75 billion in cash.

More... »


The CenterWatch Monthly, October 2014

Wednesday, October 1, 2014 06:00 AM

CROs driving changes in patient recruitment

More... »


Lumara Health to be acquired in two separate transactions

Monday, September 29, 2014 01:26 PM

Lumara Health, a Missouri-based specialty pharmaceutical company, has entered into two separate definitive agreements for the sale of its maternal health business and, separately, the sale of its women's healthcare assets.

More... »

Chiltern acquires Pacific Clinical Research, expands in Asia-Pacific

Monday, September 29, 2014 01:24 PM

Chiltern, a global clinical CRO, has acquired Pacific Clinical Research, a pan-Asian CRO based in Singapore. The move allows Chiltern to offer integrated services throughout the Asia-Pacific region and strengthens its oncology and anti-infective offerings.

More... »

Pharma & Biopharma Outsourcing Association formed

Monday, September 29, 2014 01:14 PM

Fifteen contract manufacturing organizations and contract development and manufacturing organizations (CMOs/CDMOs) have joined the Pharma & Biopharma Outsourcing Association (PBOA), a new nonprofit trade association that aims to help advance the industry's regulatory, legislative and business interests. 

More... »

Daiichi Sankyo to acquire Ambit Biosciences for $410M

Monday, September 29, 2014 01:12 PM

Daiichi Sankyo, a Japan-based pharmaceutical, will acquire all outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer, followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis.

More... »

BioMotiv, Takeda partner for medical innovation

Monday, September 29, 2014 01:06 PM

Takeda Pharmaceutical, a research-based global company headquartered in Osaka, Japan, has invested in BioMotiv, a therapeutic accelerator company associated with the Ohio-based Harrington Project for Discovery & Development, and they have partnered to identify and develop pioneering medical innovations.

More... »

Cybersecurity in Global Trials

Monday, September 29, 2014 07:00 AM

Massive data breaches have dominated global headlines in recent months, and security experts predict this trend will continue.

More... »

Medimmune, Cancer Research U.K. establish laboratory for biologic cancer medicines

Friday, September 26, 2014 03:24 PM

MedImmune, AstraZeneca’s global biologics R&D arm, and Cancer Research U.K., with its commercial arm Cancer Research Technology (CRT), have entered into an innovative collaboration to establish a joint laboratory in Cambridge, U.K. The new laboratory will focus on the discovery and development of novel biologic cancer treatments over an initial five-year period.

More... »

Radiant/CRA enrolls 8,000 in hepatitis B vaccine study

Friday, September 26, 2014 03:23 PM

Radiant Research/Clinical Research Advantage (CRA), a Tempe, Ariz., wholly owned clinical trial site management organization, has completed enrollment for the Dynavax Technologies phase III clinical trial of HEPLISAV-B, an investigational adult hepatitis B vaccine.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs